One More Gene Therapy Approved Before Year’s End – American Council on Science and Health
American Council on Science and Health |
One More Gene Therapy Approved Before Year's End
American Council on Science and Health One more gene therapy squeaked in before year's end, not for cancer treatment, but an inherited form of vision loss that can lead to blindness called biallelic RPE65 mutation-associated retinal dystrophy. The treatment is called Luxturna (voretigene … |
